Literature DB >> 28774407

The virological aspects of hepatitis B.

Zina S Valaydon1, Stephen A Locarnini2.   

Abstract

Human hepatitis B virus (HBV) is a hepatotropic virus that is responsible for a significant burden of disease, causing liver disease and hepatocellular carcinoma. It is a small DNA virus with a replication strategy that is similar to that of a retrovirus. HBV is prone to mutagenesis and under the influence of diverse selection pressures, has evolved into a pool of quasispecies, genotypes and mutants, which confers a significant survival advantage. The genome is small, circular, and compact but has a complex replication strategy. The viral life cycle involves the formation of a covalently closed circular DNA (cccDNA), which is organized into a minichromosome that is the template for the synthesis of viral mRNA. HBV DNA (double-stranded linear form) can also integrate into the host genome, ensuring lifelong persistence of the virus. To date, despite great advances in therapeutics, once HBV is chronically established, it is incurable. This is by virtue of many aspects of its virological structure and viral life cycle. In this review, we aim to discuss important aspects of the virology of HBV with a focus on clinical implications.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Genome; Hepatitis B; Mutations; Replication; Virology

Mesh:

Year:  2017        PMID: 28774407     DOI: 10.1016/j.bpg.2017.04.013

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  14 in total

1.  Conservative Evolution of Hepatitis B Virus Precore and Core Gene During Immune Tolerant Phase in Intrafamilial Transmission.

Authors:  Yuqian Luo; Le Zhang; Yimin Dai; Yali Hu; Biyun Xu; Yi-Hua Zhou
Journal:  Virol Sin       Date:  2020-03-02       Impact factor: 4.327

2.  Chronic hepatitis B: the demise of the 'inactive carrier' phase.

Authors:  Apostolos Koffas; Manoj Kumar; Upkar S Gill; Ankur Jindal; Patrick T F Kennedy; S K Sarin
Journal:  Hepatol Int       Date:  2021-02-27       Impact factor: 6.047

3.  Management of Hepatitis B Virus Infection: 2018 Guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and Infectious Disease Canada.

Authors:  Carla S Coffin; Scott K Fung; Fernando Alvarez; Curtis L Cooper; Karen E Doucette; Claire Fournier; Erin Kelly; Hin Hin Ko; Mang M Ma; Steven R Martin; Carla Osiowy; Alnoor Ramji; Edward Tam; Jean Pierre Villeneuve
Journal:  Can Liver J       Date:  2018-12-25

4.  OGG1 contributes to hepatocellular carcinoma by promoting cell cycle-related protein expression and enhancing DNA oxidative damage repair in tumor cells.

Authors:  He Zhang; Peng-Jun Jiang; Meng-Yuan Lv; Yan-Hua Zhao; Ju Cui; Jie Chen
Journal:  J Clin Lab Anal       Date:  2022-06-19       Impact factor: 3.124

5.  Detection of S-HBsAg Mutations in Patients with Hematologic Malignancies.

Authors:  Maria V Konopleva; Maxim S Belenikin; Andrei V Shanko; Alexey I Bazhenov; Sergei A Kiryanov; Tatyana A Tupoleva; Maria V Sokolova; Alexander V Pronin; Tatyana A Semenenko; Anatoly P Suslov
Journal:  Diagnostics (Basel)       Date:  2021-05-27

Review 6.  Genomics of Viral Hepatitis-Associated Liver Tumors.

Authors:  Camille Péneau; Jessica Zucman-Rossi; Jean-Charles Nault
Journal:  J Clin Med       Date:  2021-04-22       Impact factor: 4.241

Review 7.  Immune-Escape Hepatitis B Virus Mutations Associated with Viral Reactivation upon Immunosuppression.

Authors:  Ivana Lazarevic; Ana Banko; Danijela Miljanovic; Maja Cupic
Journal:  Viruses       Date:  2019-08-24       Impact factor: 5.048

8.  High prevalence and genetic diversity of hepatitis B viruses in insectivorous bats from China.

Authors:  Si-Cong Lei; Xiao Xiao; Jian-Wei Liu; Hui-Ju Han; Xiao-Qing Gong; Min Zhao; Li-Jun Wang; Xiang-Rong Qin; Xue-Jie Yu
Journal:  Acta Trop       Date:  2019-08-07       Impact factor: 3.112

Review 9.  The Role of IGF/IGF-1R Signaling in Hepatocellular Carcinomas: Stemness-Related Properties and Drug Resistance.

Authors:  Mai-Huong Thi Ngo; Han-Yin Jeng; Yung-Che Kuo; Josephine Diony Nanda; Ageng Brahmadhi; Thai-Yen Ling; Te-Sheng Chang; Yen-Hua Huang
Journal:  Int J Mol Sci       Date:  2021-02-16       Impact factor: 5.923

10.  Phylogenetic analysis and genotype distribution of Hepatitis B Virus (HBV) in Roraima, Brazil.

Authors:  Débora Dinelly de Sousa; Claudiane Raquel de Sousa Silva; Wilson Pereira Lima Junior; Jacqueline de Aguiar Barros; Ismael Alexandre da Silva Nascimento; Victor Costa de Souza; Felipe Gomes Naveca; Fabiana Granja
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2018-07-19       Impact factor: 1.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.